Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Mol Psychiatry. 2014 Dec 2;20(11):1467–1478. doi: 10.1038/mp.2014.156

Table 4.

Significant Combined and Adaptive Sum Test Results of Cumulative Rare- and Common-Variant Effects on Smoking Status in AA and EA Samples

Gene AA Sample EA Sample
Rare variant(s) Common variant(s) Effect direction P value Separated Pooled Rare variant(s) Common variant(s) Effect direction P-value
Separated Pooled
NRXN1 rs77665267
(p.T274P)
-(p.S62*)
rs10208208
rs6721498
0.5553
0.3023
0.5354
0.2996
0.5537
0.9368
0.5398
0.9275
rs77665267
(p.T274P)
rs10208208
rs10490227 0.1016
0.0527
0.0738
0.0362
0.1062
0.0772
0.0683
0.0505
- (p.R206L)
- (p.Y367*)
rs10490227
rs2193225
0.4244
0.1991
0.5232
0.3547
- (p.R206L) rs6721498
rs2193225
0.4648
0.2849
0.4506
0.4596
CHRNA9 rs139982841
(p.A452V)
0.2381
0.2381
0.2381
0.2381
0.0706
0.0766
0.1448
0.0495
rs142807401
(p.A432T)
rs55633891
(p.A315V)
0.0143
0.0143
0.0246
0.0246
0.0012
0.0032
0.0036
0.0080
rs142807401
(p.A432T)
rs56210055
(p.A312T)
rs55633891
(p.A315V)
0.0381
0.0143
0.0942
0.0353
rs56210055
(p.A312T)
rs139982841
(p.A452V)
0.0119
0.0072
0.0119
0.0072
DRD1 - (p.R226W) rs265975
rs4532
0.0572
0.0393
0.0549
0.0372
0.1121
0.0458
0.1224
0.0430
N/A
rs686 0.8101
0.8101
0.8101
0.8101
ANKK1/DRD2 rs56299709
(p.E376K)
- (p.R734C)
- (p.E181*)
rs2075654
rs111789052
(p.C52W)
rs115800217
(p.R185Q)
rs11604671
(p.G328R)
rs78229381
(p.R445C)
rs2734849
(p.H490R)
0.4445
0.1179
0.3915
0.1370
0.3915
0.0950
0.4850
0.1361
rs111789052
(p.C52W)
rs35877321
(p.R122H)
rs56299709
(p.E376K)
rs78229381
(p.R445C)
rs184645039
(p.E458G)
- (p.R734C)
rs2075654
rs4586205
0.3828
0.1708
0.2649
0.1303
0.5566
0.8627
0.4306
0.8619
rs35877321
(p.R122H)
rs56047699
(p.R237*)
- (p.S313*)
rs186633697
(p.P351S)
rs184645039
(p.E458G)
rs113005509
(p.E587*)
rs202222056
(p.Q657*)
rs2075652
rs4586205 0.4965
0.0371
0.5029
0.0273
rs115800217
(p.R185Q)
rs56047699
(p.R237*)
- (p.S313*)
rs113005509
(p.E587*)
- (p.E181*)
rs2075652
rs11604671
(p.G328R)
rs2734849
(p.H490R)
0.7714
0.3605
0.8413
0.2840
CHRNA5/ A3/B4 rs72650603
(p.H217Y)
rs8192475
(p.R37H)
- (p.R497C)
- (p.F462V)
rs56235003
(p.R349C)
- (p.P145A)
rs12914008
(p.T91I)
rs75495090
(p.N41S)
rs16969968
(p.D398N)
rs1051730
(p.Y215Y)
0.0901
0.0323
0.0701
0.0596
0.2406
0.4546
0.1398
0.4909
rs2229961
(p.V134I)
rs72650603
(p.H217Y)
rs8192475
(p.R37H)
rs588765
rs16969968
(p.D398N)
rs1051730
(p.Y215Y)
0.7389
0.2600
0.6989
0.3322
0.7570
0.9566
0.7185
0.9078
rs2229961
(p.V134I)
rs80087508
(p.K167R)
rs56218866
(p.S140G)
rs588765
rs578776
rs6495308
0.5737
0.4017
0.4497
0.4983
rs80087508
(p.K167R)
rs56235003
(p.R349C)
rs56218866
(p.S140G)
rs12914008 (p.T91I)
rs75495090
(p.N41S)
rs578776
rs6495308
0.6270
0.3729
0.5879
0.5716

Notes:

1) P values for each gene or region were obtained by four statistical methods; i.e., SKAT-C, Burden-C, SKAT-A, and Burden-A;

= p values from top to bottom for each gene or region were obtained in the abovementioned order.

2) Only genes or regions with at least one rare and one common variant were eligible for the pooled analysis; N/A = not applicable.

3) “↑” = variants increase smoking risk estimated from individual variant-based odds ratios (if available) or minor allele counts in Cases and Controls, “↓” = variants decrease smoking risk; effect direction specific tests were applied with p values listed under “Separated”.

4) SNP rs numbers are based on dbSNP database (accessed on 2/17/2014).

5) SNPs included in both AA and EA samples for this analysis are underlined.

6) Nominal significant associations (p< 0.05) for both “Pooled” and “Separated” analyses are given in bold, including p values, SNP, and gene names. See the section of “Materials and Methods” for details.